| Times (Days) |
Tested drugs groups |
Who grading |
P Value |
| 0
N (%) |
1
N (%) |
2
N (%) |
3
N (%) |
4
N (%) |
| 1 |
BenzydamineHCl |
48(55.2) |
4(23.5) |
2(50.0) |
|
|
0.051 |
| Placebo |
39(44.8) |
13(76.5) |
2(50.0) |
|
|
| BenzydamineHCl |
48(50.5) |
4(40.0) |
2(66.7) |
|
|
0.692 |
| Olive leaf |
47(49.5) |
6(60.0) |
1(33.3) |
|
|
| Olive leaf |
47(54.7) |
6(31.6) |
1(33.3) |
|
|
0.161 |
| Placebo |
39(45.3) |
13(68.4) |
2(66.7) |
|
|
| 8 |
BenzydamineHCl |
33(80.5) |
9(75.0) |
8(26.7) |
4(19.0) |
0(0.0) |
0.000 |
| Placebo |
8(19.5) |
3(25.0) |
22(73.3) |
17(81.0) |
4(100.0) |
| BenzydamineHCl |
33(42.9) |
9(52.9) |
8(80.0) |
4(100.0) |
|
0.026 |
| Olive leaf |
44(57.1) |
8(47.1) |
2(20.0) |
0(0.0) |
|
| Olive leaf |
44(84.6) |
8(72.7) |
2(8.3) |
0(0.0) |
0(0.0) |
0.00 |
| Placebo |
8(15.4) |
3(27.3) |
22(91.7) |
17(100.0) |
4(100.0) |
| 15 |
BenzydamineHCl |
41(82.0) |
9(28.1) |
4(20.0) |
0(0.0) |
|
0.000 |
| Placebo |
9(18.0) |
23(71.9) |
16(80.0) |
6(100.0) |
|
| BenzydamineHCl |
41(45.1) |
9(75.0) |
4(80.0) |
|
|
0.053 |
| Olive leaf |
50(54.9) |
3(25.0) |
1(20.0) |
|
|
| Olive leaf |
50(84.7) |
3(11.5) |
1(5.9) |
0(0.0) |
|
0.000 |
| Placebo |
9(15.3) |
23(88.5) |
16(94.1) |
6(100.0) |
|
The bold font shows the significant P value |